Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.

H2HUBB PLAIN-LANGUAGE TAKEAWAY The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit. Molecular hydrogen multiple sclerosis study: what the findings mean This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “Multiple sclerosis: Molecular mimicry […]